Rhythm Pharmaceuticals, Inc.
RYTMRhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company specializing in precision medicines for rare neuroendocrine diseases.
Earnings
Next report
Aug 4, 2026 (In 6 days)Revenue estimate$67.7M
EPS estimate-$0.82
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company specializing in precision medicines for rare neuroendocrine diseases. The company focuses on developing and commercializing melanocortin-4 receptor (MC4R) agonists to treat hyperphagia and severe obesity caused by genetic variants or acquired injuries that impair the MC4R pathway.
Competitive position
A first-mover in the MC4R pathway space with the first-ever approved therapy for Bardet-Biedl syndrome and monogenic obesity.
GeographiesUnited States, European Union, United Kingdom, Canada, Japan
Customer segmentsRare disease patients, Pediatric patients, Endocrinologists
Business modelR&D intensive, Direct-to-market pharmaceutical sales
SuppliersGenetic sequencing providers, Contract manufacturing organizations, Clinical research organizations
CustomersSpecialty distributors, Government healthcare payers, Private insurance companies, Patients with rare genetic obesity
CountryUnited States of America
Listed2017
Employees226.0
CEODavid Meeker
SectorHealthcare
IndustryBiotechnology
Websiterhythmtx.com
FilingsSEC EDGAR
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s market cap?
- Rhythm Pharmaceuticals, Inc. (RYTM) has a market capitalization of $7.3B and trades on NASDAQ.
- What is Rhythm Pharmaceuticals, Inc.'s revenue and profitability?
- Rhythm Pharmaceuticals, Inc. generated $217.2M in trailing twelve-month revenue with a net loss of $202.7M, representing a net margin of -93.3%. Gross margin stands at 89.4%. These figures are based on the Q1 2026 filing.
- Who are Rhythm Pharmaceuticals, Inc.'s competitors?
- Rhythm Pharmaceuticals, Inc.'s key competitors include Eli Lilly, Palatin Technologies, Inc., Viking Therapeutics, Inc, and others. These companies compete in similar markets and product categories.
- Who does Rhythm Pharmaceuticals, Inc. partner with?
- Rhythm Pharmaceuticals, Inc.'s notable partners include U.S. Food and Drug Administration, European Commission.
- Where is Rhythm Pharmaceuticals, Inc. headquartered?
- Rhythm Pharmaceuticals, Inc. is headquartered in United States of America and employs approximately 226 people. It has been publicly traded since 2017.
